Literature DB >> 32165485

IGH rearrangement in myeloid neoplasms.

Amy W Xiao1, Yuyan Jia1, Linda B Baughn2, Kathryn E Pearce2, Beth A Pitel2, Jon C Aster1, Paola Dal Cin1, Sheng Xiao3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32165485      PMCID： PMC7271583          DOI： 10.3324/haematol.2020.246744

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia.

Authors:  X Qiu; X Sun; Z He; J Huang; F Hu; L Chen; P Lin; M J You; L J Medeiros; C C Yin
Journal:  Leukemia       Date:  2012-07-09       Impact factor: 11.528

2.  Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).

Authors:  Jose R Valbuena; L Jeffrey Medeiros; George Z Rassidakis; Suyang Hao; C Daniel Wu; Lei Chen; Pei Lin
Journal:  Am J Clin Pathol       Date:  2006-08       Impact factor: 2.493

Review 3.  Enhancer-promoter communication and transcriptional regulation of Igh.

Authors:  Ananda L Roy; Ranjan Sen; Robert G Roeder
Journal:  Trends Immunol       Date:  2011-08-19       Impact factor: 16.687

4.  High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.

Authors:  Guido Marcucci; Kati Maharry; Susan P Whitman; Tamara Vukosavljevic; Peter Paschka; Christian Langer; Krzysztof Mrózek; Claudia D Baldus; Andrew J Carroll; Bayard L Powell; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

5.  Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia.

Authors:  U Rovigatti; J Mirro; G Kitchingman; G Dahl; J Ochs; S Murphy; S Stass
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

6.  Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.

Authors:  K Morishita; E Parganas; T Matsugi; J N Ihle
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

7.  A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.

Authors:  Hiromi Yamazaki; Mikiko Suzuki; Akihito Otsuki; Ritsuko Shimizu; Emery H Bresnick; James Douglas Engel; Masayuki Yamamoto
Journal:  Cancer Cell       Date:  2014-04-03       Impact factor: 31.743

8.  Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1.

Authors:  Haeng Ran Seo; Joon Kim; Sangwoo Bae; Jae-Won Soh; Yun-Sil Lee
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

9.  Rexin-G®, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.

Authors:  Seth Kim; Noah Federman; Erlinda M Gordon; Frederick L Hall; Sant P Chawla
Journal:  Mol Clin Oncol       Date:  2017-04-28

10.  LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Authors:  HaiDan Liu; Hui Zheng; Zhi Duan; DuoSha Hu; Ming Li; SuFang Liu; ZiJian Li; XiYun Deng; ZhenLian Wang; Min Tang; Ying Shi; Wei Yi; Ya Cao
Journal:  Mol Cancer       Date:  2009-10-27       Impact factor: 27.401
View more
  1 in total

1.  Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma.

Authors:  Yanglan Fang; Man Wang; Shuhong Hu; Tanzhen Wang; Yujie Liu; Jinyan Xiao; Yiming Cai; Ying Wang; Huiying Qiu; Xiaowen Tang; Suning Chen; Depei Wu; Yang Xu; Tianhui Liu
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.